Benefits and risks of anthracyclines in early-stage breast cancer - Authors' reply
- PMID: 38555133
- DOI: 10.1016/S0140-6736(23)02890-8
Benefits and risks of anthracyclines in early-stage breast cancer - Authors' reply
Comment on
-
Benefits and risks of anthracyclines in early-stage breast cancer.Lancet. 2024 Mar 30;403(10433):1239-1240. doi: 10.1016/S0140-6736(23)02889-1. Lancet. 2024. PMID: 38555132 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
